We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Hyperoxemia on Platelet Function in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01057420
Recruitment Status : Completed
First Posted : January 27, 2010
Last Update Posted : August 24, 2010
Sponsor:
Information provided by:
University of Zurich

Brief Summary:

Prospective, controlled, randomized crossover volunteer study to investigate the effect of hyperoxemia due to inhalation of oxygen (80% inspiratory fraction) via reservoir-face-mask on blood coagulation, especially platelet function, as measured by thrombelastography. According to results of basic animal and in vitro investigations, hyperoxemia may activate platelets by means of reactive oxygen species. This study aims at investigating a possible pro-coagulant effect of hyperoxemia in healthy volunteers. Additional studies on possible mechanisms are integrated.

  • Trial with medical device

Condition or disease Intervention/treatment Phase
Healthy Volunteers Drug: oxygen inhalation Phase 4

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effect of Hyperoxemia on Platelet Function in Healthy Volunteers
Study Start Date : April 2009
Primary Completion Date : March 2010
Study Completion Date : May 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Oxygen Therapy
U.S. FDA Resources

Arm Intervention/treatment
Inhalation of 80% Oxygen
Inhalation of 80% Oxygen by nonrebreathing reservoir face masks for 4 hours
Drug: oxygen inhalation
Inhalation of 80% oxygen via face mask



Primary Outcome Measures :
  1. maximum amplitude in thrombelastography [ Time Frame: 1 hour ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   25 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion criteria:

  • informed consent; no coagulation disorder or other illnesses;
  • non-smoker;
  • women: no pharmacological contraception, negative pregnancy test;
  • 25-45 years old; no medication; no acute or chronic airway problems;
  • for 24 hours before study: no extreme physical activity, no polyphenol-containing food (red wine, apples, cabbage, garlic);
  • for 48 hours: no caffeine-containing drinks, no dark chocolate.

Exclusion criteria:

  • Lack of one of the inclusion criteria;
  • allergy or incompatibility to substances/materials applied in the study;
  • very thin veins/arteries.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01057420


Locations
Switzerland
Surgical Intensive Care Medicine
Zurich, Switzerland, CH-8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Johannes Wacker, MD Surgical Intensive Care Medicine, UniversitaetsSpital Zuerich
Study Director: Reto Stocker, Prof., MD Surgical Intensive Care Medicine, UniversitaetsSpital Zurich

Responsible Party: Johannes Wacker, MD, Surgical Intensive Care Medicine, UniversitaetsSpital Zurich
ClinicalTrials.gov Identifier: NCT01057420     History of Changes
Other Study ID Numbers: O2Tc-2009
First Posted: January 27, 2010    Key Record Dates
Last Update Posted: August 24, 2010
Last Verified: August 2010